NCT01786434

Brief Summary

Colonoscopy may be an unpleasant procedure. Sedation and/or analgesics is therefore routinely administered in most countries. In Norway, however, routine sedation is rare, and medication is normally given on demand, that is, if necessary during the procedure. The investigators want to evaluate whether the effect of fentanyl, a synthetic opioid with fast onset of action, is better given before the procedure than during the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
119

participants targeted

Target at P75+ for not_applicable pain

Timeline
Completed

Started Dec 2012

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2012

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 8, 2013

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

April 6, 2022

Status Verified

March 1, 2022

Enrollment Period

2.6 years

First QC Date

January 3, 2013

Last Update Submit

March 25, 2022

Conditions

Keywords

colonoscopypain

Outcome Measures

Primary Outcomes (1)

  • Pain during colonoscopy

    Pain is recorded on a 4 point Likert scale and a 100 mm VAS scale.

    Immediately after the procedure and after 24 hours

Secondary Outcomes (1)

  • Additional medication

    During the colonoscopy

Other Outcomes (6)

  • Patient satisfaction

    The day after the procedure

  • Complications

    During the procedure

  • Caecum intubation time

    During the procedure

  • +3 more other outcomes

Study Arms (2)

Routine medication arm

EXPERIMENTAL

Fentanyl is given routinely to all patients before the procedure

Drug: Routine medication arm

Fentanyl on-demand arm

ACTIVE COMPARATOR

Fentanyl is given during the procedure if the patient experiences pain

Drug: Fentanyl on-demand arm

Interventions

50 micrograms of fentanyl given before the procedure

Also known as: fentanyl
Routine medication arm

Fentanyl 50 microgram is provided on-demand, that is, if the patient has pain during the procedure.

Also known as: Fentanyl
Fentanyl on-demand arm

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-75
  • Referred for out-patient colonoscopy

You may not qualify if:

  • ASA-score 3 or higher
  • Same day upper endoscopy
  • Pregnancy
  • Pacemaker
  • Patient require medication before colonoscopy
  • Previous resection of colon or rectum
  • Significant psychiatric morbidity
  • Oxygen saturation \< 95% without supplementary oxygen
  • Contra indications to fentanyl
  • Inability to sign inform consent
  • Inability to understand information about the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sorlandet Hospital Kristiansand

Kristiansand, Norway

Location

Related Publications (1)

  • Holme O, de Lange T, Stallemo A, Wiig H, Hasund A, Dvergsnes K, Garborg K, Ystrom CM, Loberg M, Hoff G, Bretthauer M, Kalager M. Routine vs. on-demand analgesia in colonoscopy: a randomized clinical trial. Endoscopy. 2016 Sep;48(9):823-8. doi: 10.1055/s-0042-108433. Epub 2016 Jun 15.

MeSH Terms

Conditions

Pain

Interventions

Fentanyl

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Oyvind Holme, MD

    Sorlandet Hospital HF

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2013

First Posted

February 8, 2013

Study Start

December 10, 2012

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

April 6, 2022

Record last verified: 2022-03

Locations